March 11, 2024
Arthur Bradley, PhD
SAN RAMON, Calif. — CooperVision’s Arthur Bradley, PhD, was honored by the Wavefront Congress as a 2024 Luminary for his outstanding contributions to the optometry field for more than four decades, particularly for his groundbreaking research on optical interventions that address the myopia epidemic.
The honor was awarded to him during the annual event held in Houston this month, which drew over 100 optical scientists, clinicians, surgeons, and corporate scientists from around the world. In addition to receiving his Luminary recognition, Dr. Bradley shared insights from his seven-year trial on the cumulative treatment effect and efficacy of MiSight 1 day contact lenses, presenting findings derived from the multi-year international clinical study. A prolific researcher, Dr. Bradley has authored nearly 200 scientific papers and over 200 abstracts to date.
Before joining CooperVision in 2019, Dr. Bradley built a celebrated career as a vision science professor and researcher at Indiana University. Throughout his tenure, he provided mentorship and guidance to the thousands of students he taught in various fields, including optics, visual neuroscience, binocular vision, and visual function.
“Dr. Bradley has made significant contributions to the field of optometry, especially in developing novel ways to examine the visual and ophthalmic systems,” said Francis Erard, CooperVision’s Vice President of Research and Development. “For decades he has been a Luminary to thousands of young scientists, as well as optometrists, ophthalmologists, and research peers, encouraging a deeper understanding of human vision and optics.”
Dr. Bradley and the CooperVision Research and Development myopia team have garnered global recognition for groundbreaking research on optical interventions that address the myopia epidemic.* His significant contributions, particularly in the context of MiSight 1 day, have propelled the fields of myopia control and myopia management forward. Dr. Bradley’s work continues to receive widespread recognition and is regularly featured at major conferences. Last year, Dr. Bradley was inducted into the University of California Berkeley School of Optometry’s Hall of Fame.
“Guiding the next generation of research scientists is an essential aspect of the scientific journey,” said Dr. Bradley. “Whether in a university or corporate setting, I believe we have an innate mentorship responsibility. Hopefully, this recognition will help shine a brighter spotlight on opportunities to collaborate with emerging ocular scientists, building an even more promising future together.”
Dr. Bradley was named a 2024 Luminary along with Dr. Ray Applegate, Dr. Larry Thibos, and Dr. Jim Schwiegerling (posthumously).
* MiSight 1 day clinical study is the longest continuous soft contact lens study for myopia management.
